Turn Therapeutics (TTRX) Total Current Liabilities (2024 - 2026)

Turn Therapeutics' Total Current Liabilities history runs 3 years deep, the most recent figure standing at $5.1 million for Q1 2026.

• In Q1 2026, Total Current Liabilities changed N/A year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $5.1 million (changed N/A YoY), while the FY2025 annual figure was $6.0 million, up 748.02% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $5.1 million, down from $6.0 million in the prior quarter.
• The five-year high for Total Current Liabilities was $6.0 million in Q4 2025, with the low at $707932.0 in Q4 2024.
• The 3-year median for Total Current Liabilities is $3.7 million (2025), against an average of $3.5 million.
• Peak annual rise in Total Current Liabilities reached 748.02% in 2025, while the deepest fall reached 748.02% in 2025.
• Turn Therapeutics' Total Current Liabilities stood at $707932.0 in 2024, then jumped by 748.02% to $6.0 million in 2025, then fell by 14.54% to $5.1 million in 2026.
• Business Quant data shows TTRX's Total Current Liabilities at $5.1 million in Q1 2026, $6.0 million in Q4 2025, and $2.3 million in Q3 2025.